BIT Analytical Expands Clinical Chemistry, Immunology, Molecular Offerings

The purchase price was not revealed.

The acquisition will enable BIT to offer a larger range of services and technologies in areas of clinical chemistry, immunology, and molecular diagnostics. BIT Companies provide a full, turnkey portfolio for in vitro diagnosis (IVD) market OEMs

C2 is a leader in contract development, design, manufacture, and support of custom instrumentation for the diagnostic equipment industry, with a specialty in hematology. The company specializes in developing OEM instruments and has delivered and sold more than 10,000 instruments to small and mid-size diagnostic labs worldwide. The company is currently focused on developing a new hematology instrument.

With expertise in mechanics, optics, software, electronics, fluidics, and chemistry, C2 Diagnostics (C2D) also holds several in vitro diagnostics (IVD) patents. The company has its own 929-m2 facility that is registered by the FDA as a contract manufacturer

C2D is currently focused on hematology application, which has an end-user segment with a growing market size. The company's product offering is a family of over 10 models of compact, easy to operate, robust, and cost efficient diagnostic instruments.

Related Links:
BIT Analytical Instrument
C2 Diagnostics